TERF2 and cancer: Interestingly, TRF2 Immunoreactive score (IRS), obtained by multiplying the TRF2 positive cells proportion score for the TRF2 staining intensity score, progressively increased from normal tissue to benign lesions and became even higher in malignant tumors (Fig. 5A, B).